Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01521000
What this trial is testing

The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer Patient

Who this might be right for
Breast Cancer
Main Line Health 200
Testing effectiveness (Phase 2)Study completedNCT00253500
What this trial is testing

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 15
Not applicableEnded earlyNCT01351844
What this trial is testing

The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Who this might be right for
Breast CancerArthralgia
George Washington University 12
Not applicableLooking for participantsNCT02290834
What this trial is testing

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Who this might be right for
Impaired CognitionChemo-brainBreast Cancer
Massachusetts General Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT02137837
What this trial is testing

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 37
Not applicableStudy completedNCT05635357
What this trial is testing

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

Who this might be right for
Breast Cancer
Brigham and Women's Hospital 16,989
Not applicableActive Not RecruitingNCT04532177
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery

Who this might be right for
Breast Cancer
Stony Brook University 15
Testing effectiveness (Phase 2)Ended earlyNCT02318901
What this trial is testing

Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer

Who this might be right for
Advanced CancerBreast CancerGastric Cancer+2 more
Western Regional Medical Center 16
Large-scale testing (Phase 3)Study completedNCT01530607
What this trial is testing

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 416
Not applicableStudy completedNCT06370234
What this trial is testing

The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.

Who this might be right for
Breast CancerChemotherapy EffectDiffusion Weighted MRI+2 more
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04570956
What this trial is testing

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Who this might be right for
Breast Atypical HyperplasiaBreast Lobular Carcinoma in SituBreast Atypical Lobular Hyperplasia+1 more
Mayo Clinic 65
Large-scale testing (Phase 3)Active Not RecruitingNCT03734029
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Who this might be right for
Breast Cancer
Daiichi Sankyo 557
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableStudy completedNCT03282812
What this trial is testing

Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition Cohort

Who this might be right for
Breast Cancer
American Cancer Society, Inc. 1,547
Not applicableStudy completedNCT00584428
What this trial is testing

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
University of Oklahoma 61
Large-scale testing (Phase 3)Study completedNCT00513136
What this trial is testing

Fatigue Intervention Trial for Breast Cancer Survivors

Who this might be right for
Fatigue
Mercy Medical Center 36
Not applicableStudy completedNCT01811264
What this trial is testing

Improving Psychosocial Quality of Life in Women With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University 150
Testing effectiveness (Phase 2)Study completedNCT02073487
What this trial is testing

Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel

Who this might be right for
Breast Cancer
The Methodist Hospital Research Institute 32
Post-approval studies (Phase 4)Study completedNCT03664687
What this trial is testing

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)

Who this might be right for
Early-stage Breast Cancer
Ottawa Hospital Research Institute 211
Not applicableLooking for participantsNCT06605521
What this trial is testing

To Evaluate the Efficacy and Safety of Ipsilateral Supraclavicular Lymph Node Dissection for Breast Cancer Patients

Who this might be right for
Locally Advanced Breast Cancer
Henan Cancer Hospital 300
Next Page